Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations

Urology

Volumn 86, Issue 6, 2015, Pages 1212-1217

  Joost, Patrick ^a,b   Therkildsen, Christina ^a,b   Dominguez Valentin, Mev ^a,b   Jönsson, Mats ^a,b   Nilbert, Mef ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ARABIDOPSIS PROTEIN; DNA BINDING PROTEIN; DNA LIGASE; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; MSH6 PROTEIN, ARABIDOPSIS; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

AGED; ANIMAL; CARCINOMA, TRANSITIONAL CELL; DENMARK; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; PEDIGREE; RISK FACTOR; UROLOGIC NEOPLASMS; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; AGED; AGED, 80 AND OVER; ANIMALS; ARABIDOPSIS PROTEINS; CARCINOMA, TRANSITIONAL CELL; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DENMARK; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; NUCLEAR PROTEINS; PEDIGREE; RISK FACTORS; UROLOGIC NEOPLASMS;

EID: 84955709593     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.08.018     Document Type: Article

References (30)

1. E. Stoffel, B. Mukherjee, V.M. Raymond, and et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome Gastroenterology 137 2009 1621 1627
2. M. Aarnio, R. Sankila, E. Pukkala, and et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 1999 214 218
3. V. Bonadona, B. Bonaiti, S. Olschwang, and et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome JAMA 305 2011 2304 2310
4. A.K. Win, N.M. Lindor, J.P. Young, and et al. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome J Natl Cancer Inst 104 2012 1363 1372
5. H.T. Lynch, and A. de la Chapelle Hereditary colorectal cancer N Engl J Med 348 2003 919 932
6. H.F. Vasen, A. Stormorken, F.H. Menko, and et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families J Clin Oncol 19 2001 4074 4080
7. D.G. Crockett, D.G. Wagner, S. Holmang, S.L. Johansson, and H.T. Lynch Upper urinary tract carcinoma in Lynch syndrome cases J Urol 185 2011 1627 1630
8. P. Watson, H.F. Vasen, J.P. Mecklin, and et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome Int J Cancer 123 2008 444 449
9. R.H. Sijmons, L.A. Kiemeney, J.A. Witjes, and H.F. Vasen Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options J Urol 160 1998 466 470
10. P. Watson, and H.T. Lynch The tumor spectrum in HNPCC Anticancer Res 14 1994 1635 1639
11. P. Mongiat-Artus, C. Miquel, M. Van der Aa, and et al. Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract Oncogene 25 2006 2113 2118
12. M. Roupret, D.R. Yates, E. Comperat, and O. Cussenot Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum Eur Urol 54 2008 1226 1236
13. S.C. Skeldon, K. Semotiuk, M. Aronson, and et al. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer Eur Urol 63 2013 379 385
14. R.S. van der Post, L.A. Kiemeney, M.J. Ligtenberg, and et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers J Med Genet 47 2010 464 470
15. M. Roupret, J. Catto, F. Coulet, and et al. Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma J Med Genet 41 2004 e91
16. K.M. Ericson, A.P. Isinger, B.L. Isfoss, and M.C. Nilbert Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma BMC Cancer 5 2005 23
17. C. Bonnal, V. Ravery, M. Toublanc, and et al. Absence of microsatellite instability in transitional cell carcinoma of the bladder Urology 55 2000 287 291
18. P. Mongiat-Artus, C. Miquel, M. van der Aa, and et al. Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients Eur Urol 49 2006 685 690
19. P. Joost, N. Veurink, S. Holck, and et al. Heterogenous mismatch-repair status in colorectal cancer Diagn Pathol 9 2014 126
20. E. Barrow, L. Robinson, W. Alduaij, and et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations Clin Genet 75 2009 141 149
21. C. Engel, M. Loeffler, V. Steinke, and et al. Risks of less common cancers in proven mutation carriers with lynch syndrome J Clin Oncol 30 2012 4409 4415
22. T. Myrhoj, M.B. Andersen, and I. Bernstein Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer Fam Cancer 7 2008 303 307
23. G. Engholm, J. Ferlay, N. Christensen, and et al. NORDCAN - a Nordic tool for cancer information, planning, quality control and research Acta Oncol 49 2010 725 736
24. J.L. Bermejo, C. Eng, and K. Hemminki Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer Gastroenterology 129 2005 1889 1899
25. J. Geary, P. Sasieni, R. Houlston, and et al. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC) Fam Cancer 7 2008 163 172
26. P.J. Barrow, S. Ingham, C. O'Hara, and et al. The spectrum of urological malignancy in Lynch syndrome Fam Cancer 12 2013 57 63
27. H.F. Vasen, I. Blanco, K. Aktan-Collan, and et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts Gut 62 2013 812 823
28. F.M. Giardiello, J.I. Allen, J.E. Axilbund, and et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer Gastroenterology 147 2014 502 526
29. J.J. Koornstra, M.J. Mourits, R.H. Sijmons, A.M. Leliveld, H. Hollema, and J.H. Kleibeuker Management of extracolonic tumours in patients with Lynch syndrome Lancet Oncol 10 2009 400 408
30. P. Acher, G. Kiela, K. Thomas, and T. O'Brien Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma BJU Int 106 2010 300 302